STOCK TITAN
  1. Home
  2. Sec-filings
  3. PACS
  4. [Form 4] PACS Group, Inc. Insider Trading Activity

PACS Group (NASDAQ: PACS) CEO sells August shares under trading plan

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) director and Co-Founder, CEO & Chairman Murray Jason Hulse reported open-market sales of an aggregate 150,550 shares of common stock on August 20–21, 2026, in multiple transactions at weighted average prices in the low-to-mid $40s per share, effected under a Rule 10b5-1 trading plan adopted on May 18, 2026.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Murray Jason Hulse
Role Co-Founder, CEO & Chairman
Sold 150,550 shs ($6.61M)
Type Security Shares Price Value
Sale Common Stock F1, F4 31,654 $43.6063 $1.38M
Sale Common Stock F1, F5 27,590 $44.2469 $1.22M
Sale Common Stock F1, F2 77,427 $43.7714 $3.39M
Sale Common Stock F1, F3 13,879 $44.7625 $621K
Holdings After Transaction: Common Stock — 54,694,866 shares (Direct)
Footnotes (5)
  1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Total shares sold 150,550 shares of Common Stock Aggregate open-market sales reported for August 20–21, 2026
Shares sold on 2026-08-20 (block 1) 77,427 shares at $43.7714 per share Non-derivative sale, weighted average price; prices ranged $43.30–$44.29
Shares sold on 2026-08-20 (block 2) 13,879 shares at $44.7625 per share Non-derivative sale, weighted average price; prices ranged $44.31–$45.165
Shares sold on 2026-08-21 (block 1) 31,654 shares at $43.6063 per share Non-derivative sale, weighted average price; prices ranged $43.05–$44.045
Shares sold on 2026-08-21 (block 2) 27,590 shares at $44.2469 per share Non-derivative sale, weighted average price; prices ranged $44.05–$44.52
Rule 10b5-1 plan adoption date May 18, 2026 Trading plan under which all reported sales were effected
Rule 10b5-1 trading plan regulatory
"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"transaction_code_description": "Sale in open market or private transaction""
non-derivative financial
""transaction_type": "non-derivative""

FAQ

What insider activity did PACS (PACS Group, Inc.) disclose in this Form 4?
PACS reported that Murray Jason Hulse, its Co-Founder, CEO & Chairman, sold a total of 150,550 shares of common stock in open-market transactions on August 20–21, 2026, at weighted average prices in the low-to-mid $40s per share.

Were the August 2026 PACS (PACS) stock sales made under a Rule 10b5-1 plan?
Yes. The Form 4 states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Murray Jason Hulse on May 18, 2026, indicating the transactions followed a pre-established trading arrangement.

How many PACS (PACS) shares did Murray Jason Hulse sell on August 20, 2026?
On August 20, 2026, Murray Jason Hulse sold 77,427 shares at a weighted average price of $43.7714 per share and 13,879 shares at a weighted average price of $44.7625 per share, in multiple transactions within specified price ranges.

How many PACS (PACS) shares did Murray Jason Hulse sell on August 21, 2026?
On August 21, 2026, he sold 31,654 shares at a weighted average price of $43.6063 per share and 27,590 shares at a weighted average price of $44.2469 per share, with each sale executed through multiple trades within stated price ranges.

What were the price ranges for the PACS (PACS) insider sales reported?
The Form 4 notes weighted average prices, with underlying trades in ranges of $43.30–$44.29, $44.31–$45.165, $43.05–$44.045, and $44.05–$44.52 per share. Detailed breakdowns are available on request from the issuer or the SEC staff.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Murray Jason Hulse
(Last)(First)(Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700
(Street)
SALT LAKE CITY UTAH 84101
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Co-Founder, CEO & Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/20/2026S(1)77,427D$43.7714(2)54,767,989D
Common Stock08/20/2026S(1)13,879D$44.7625(3)54,754,110D
Common Stock08/21/2026S(1)31,654D$43.6063(4)54,722,456D
Common Stock08/21/2026S(1)27,590D$44.2469(5)54,694,866D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.30 to $44.29 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.31 to $45.165 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.05 to $44.045 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.05 to $44.52 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell, Attorney-in-Fact08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR